Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer.

Abstract

The phosphoinositide 3-kinase (PI3K)/AKT signaling pathway plays a crucial role in the pathogenesis of cancer. The dysregulation of this pathway has been linked to the development and initiation of various types of cancer. Recently, epigenetic modifications, particularly N6-methyladenosine (m6A), have been recognized as essential contributors to mRNA-related biological processes and translation. The abnormal expression of m6A modification enzymes has been associated with oncogenesis, tumor progression, and drug resistance. Here, we review the role of m6A modification in regulating the PI3K/AKT pathway in cancer and its implications in the development of novel strategies for cancer treatment.

• Authors: Jie Liu, Xinyu Gu, Zhenjie Guan, Di Huang, Huiwu Xing, Lian Zheng
• Journal: Journal of translational medicine (J Transl Med) Vol. 21 Issue 1 Pg. 774 (11 01 2023) ISSN: 1479-5876 [Electronic] England
• PMID: 37915034 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
• Copyright: © 2023. The Author(s).

Chemical References

• Phosphatidylinositol 3-Kinases
• Proto-Oncogene Proteins c-akt
• Phosphatidylinositol 3-Kinase

Topics

• Humans
• Phosphatidylinositol 3-Kinases
• Proto-Oncogene Proteins c-akt
• Neoplasms (genetics)
• Phosphatidylinositol 3-Kinase
• Signal Transduction